These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14558342)

  • 1. [Effect of pyracetam on the color discriminative function of retina in patients with craniocerebral trauma].
    Ovanesov KB; Shikina IB; Arushanian EB; Shchurovskaia IIu
    Eksp Klin Farmakol; 2003; 66(4):6-8. PubMed ID: 14558342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of piracetam on photosensitivity of the retina and timing of the visual-motor reaction with head injury].
    Ovanesov KB; Ivanov AV; Shikina IB; Shchurovskaia IIu
    Eksp Klin Farmakol; 2002; 65(6):64-6. PubMed ID: 12596538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of tofisopam and tinctura leonuri on the color-discrimination function in young humans].
    Ovanesov KB
    Eksp Klin Farmakol; 2005; 68(3):56-9. PubMed ID: 16047683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative action of melatonin and bilobil on light perception and psychophysiological indices in patients with cerebral trauma anamnesis].
    Arushanian EB; Ovanesov KB; Ovanesova IM
    Eksp Klin Farmakol; 2007; 70(2):20-3. PubMed ID: 17523445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of caffeine on the color-discriminating function of the retina in volunteers].
    Ovanesov KB
    Eksp Klin Farmakol; 1998; 61(6):17-9. PubMed ID: 9929810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of nootropic agents on brain mitochondrial function in the dynamics of craniocerebral trauma from the age aspect].
    Novikov VE; Kovaleva LA
    Eksp Klin Farmakol; 1998; 61(2):65-8. PubMed ID: 9621180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of nootropic agents on the brain bioelectrical activity and on the indices of neuromediator metabolism in the acute period of severe craniocerebral trauma].
    Madorskiĭ SV; Potapov AA; Piasetskaia MV; Shapova EV; Il'icheva RF
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (3):29-35. PubMed ID: 2572097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Does treatment with piracetam in stroke patients with aphasia make sense?].
    Schmidtke K
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2636. PubMed ID: 12469280
    [No Abstract]   [Full Text] [Related]  

  • 9. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy.
    Piazzini A; Chifari R; Canevini MP; Turner K; Fontana SP; Canger R
    Epilepsy Res; 2006 Mar; 68(3):181-8. PubMed ID: 16332430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
    Salomão SR; Watanabe SE; Berezovsky A; Motono M
    Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents.
    Zavadenko NN; Guzilova LS
    Neurosci Behav Physiol; 2009 May; 39(4):323-8. PubMed ID: 19340573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piracetam therapy for Down syndrome: a rush to judgment?
    Black SL
    Arch Pediatr Adolesc Med; 2001 Oct; 155(10):1176; author reply 1177-8. PubMed ID: 11576019
    [No Abstract]   [Full Text] [Related]  

  • 13. Piracetam: a novel therapy for autism?
    Paczynski M
    J Autism Dev Disord; 1997 Oct; 27(5):628-30. PubMed ID: 9403377
    [No Abstract]   [Full Text] [Related]  

  • 14. Piracetam study: poorly designed and misinterpreted.
    Croom J
    Arch Pediatr Adolesc Med; 2001 Oct; 155(10):1176-8. PubMed ID: 11576020
    [No Abstract]   [Full Text] [Related]  

  • 15. [The efficacy of piracetam in treating patients with chronic bronchitis and concomitant atherosclerosis].
    Nikitin AV; Chesnokova IV; Sysoeva LI
    Vrach Delo; 1990 Nov; (11):17-8. PubMed ID: 2098971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of neurotropic and stress-protective properties of piracetam and the derivative pyrido]1,2-a]pyrimidine].
    Kozlovskaia MM; Inozemtsev AN; Nikitin SV; Gochmuradov AG; Iakushev RA; Chabak-Gorbach R
    Biull Eksp Biol Med; 1995 Mar; 119(3):299-301. PubMed ID: 7795202
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimyoclonic efficacy of piracetam in idiopathic generalized epilepsy.
    Khani YA; Andermann F; Andermann E
    Epilepsia; 2005 Jul; 46(7):1145-6. PubMed ID: 16026569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piracetam--an old drug with novel properties?
    Winnicka K; Tomasiak M; Bielawska A
    Acta Pol Pharm; 2005; 62(5):405-9. PubMed ID: 16459490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of individual resistance to hypoxia for correction of the consequences of craniocerebral trauma.
    Zarubina IV; Shabanov PD
    Neurosci Behav Physiol; 2005 Feb; 35(2):215-9. PubMed ID: 15779336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of fast-acting adaptogens and symptomatic means during evacuation of trauma victims by air transportation].
    Grechko AT; Glaznikov LA
    Aviakosm Ekolog Med; 1997; 31(2):47-9. PubMed ID: 9190256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.